Implications of blood type in personalised microbiome therapy

Yue Zhang; Ranko Gacesa; Jingyuan Fu

doi:10.1002/ctm2.1618

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (3) : e1618 DOI: 10.1002/ctm2.1618

COMMENTARY

Implications of blood type in personalised microbiome therapy

Yue Zhang ¹
, Ranko Gacesa ¹^,²
, Jingyuan Fu ¹^,³^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Yue Zhang, Ranko Gacesa, Jingyuan Fu. Implications of blood type in personalised microbiome therapy. Clinical and Translational Medicine, 2024, 14(3): e1618 DOI:10.1002/ctm2.1618

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Zhernakova DV, Wang D, Liu L, et al. Host genetic regulation of human gut microbial structural variation. Nature. 2024;625:813-821.

[2]	Van Rossum T, Ferretti P, Maistrenko OM, Bork P. Diversity within species: interpreting strains in microbiomes. Nat Rev Microbiol. 2020;18:491-506.

[3]	Ferreiro A, Crook N, Gasparrini AJ, Dantas G. Multiscale evolutionary dynamics of host-associated microbiomes. Cell. 2018;172:1216-1227.

[4]	Abegaz SB. Human ABO blood groups and their associations with different diseases. Biomed Res Int. 2021:6629060.

[5]	Pereira E, Araújo V, Soares P, et al. ABO blood group and link to COVID-19: a comprehensive review of the reported associations and their possible underlying mechanisms. Microb Pathog. 2022;169:105658.

[6]	Zhernakova DV, Deelen P, Franke L, et al. Individual variations in cardiovascular-disease-related protein levels are driven by genetics and gut microbiome. Nat Genet. 2018;50:1524-1532.

[7]	Parsaei M, Sarafraz N, Moaddab SY, Ebrahimzadeh Leylabadlo H. The importance of Faecalibacterium prausnitzii in human health and diseases. New Microbes New Infect. 2021;43:100928.

[8]	Khan MT, Dwibedi C, Sundh D, et al. Synergy and oxygen adaptation for development of next-generation probiotics. Nature. 2023;620:381-385.

[9]	Behrouzi A, Nafari AH, Siadat SD. The significance of microbiome in personalized medicine. Clin Transl Med. 2019;8:16.

[10]	Routy B, Jamal R, Messaoudene M, et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat Med. 2023;29:2121-2132.

[11]	Baruch EN, Youngster I, Ben-Betzalel G, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021;371:602-609.

[12]	Gao Y, Xu P, Sun D, et al. Faecalibacterium prausnitzii abrogates intestinal toxicity and promotes tumor immunity to increase the efficacy of dual CTLA4 and PD-1 checkpoint blockade. Cancer Res. 2023;83:3710-3725.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.